• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Rtw Biotech Opportunities LTD (RTW)

ORD NPV
Sell: $2.26|Buy: $2.29|Change: 0.05 (2.25%)

Open 

$2.22

Previous close 

$2.22

Trade high 

$2.29

Estimated NAV 

2.92 

Year high 

$2.64

Year low 

$1.58

Premium / Discount 

-23.97%

Market capitalisation 

$728.99 mn

Volume 

198,462

Dividend yield 

–

Ongoing charge 

1.74%

ISIN 

GG00BKTRRM22

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Before investing please read:

Key Information Document (KID/KIID)/Product Summary

Share price

Net asset value (NAV)

Estimated NAV2.92
Latest actual NAV2.92
Latest actual NAV date31 August 2026
12m average premium/discount-15.75%

Top 10 holdings

Holdings 31/12/2025% of assets
PTC Inc11.65
CORXEL Pharmaceuticals6.23
Stoke Therapeutics Inc5.18
UroGen Pharma Ltd5.03
Insmed Inc3.90
Kailera Therapeutics3.41
Tarsus Group PLC2.80
Immatics NV Ordinary Shares2.74
argenx SE2.19
Madrigal Pharmaceuticals Inc1.92

Performance 30/09/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Fund+ 2.25
Category-
More...

Investment objective

The Company seeks to achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies. It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.

Morningstar ratingTM

  Morningstar report document

News

Recent trades

DateTimePriceQuantityValue
12/10/202602:48:222.271,0882,469.76
12/10/202602:43:462.27228517.56
12/10/202602:43:462.271,4043,187.08
12/10/202602:43:462.275841,325.68
12/10/202602:43:462.271,0882,469.76

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.